Racepinephrine

• Uses For temporary relief of mild symptoms of intermittent asthma: Wheezing Tightness of chest Shortness of breathICD-10: J45.909

Directions The ingredient is used in an aqueous solution at a concentration equivalent to 1 percent epinephrine. Do not use more than directed For use with a Jet or Ultrasonic Nebulizer. Add 0.5 mL (contents of one vial) of solution to Nebulizer. Adults and children 4 years of age and over: 1 to 3 inhalations not more often than every 3 hours. Do not use more than 12 inhalations in 24 hours. The use of this product by children should be supervised by an adult. Children under 4 years of age: ask a doctor.

Asthma alert: Because asthma may be life threatening, see a doctor if you: Are not better in 20 minutes Get worse Need more than 12 inhalations in 24 hours Use more than 9 inhalations in 24 hours for 3 or more days a week Have more than 2 asthma attacks in a week These may be signs that your asthma is getting worse. Do not use: Unless a doctor said you have asthma If you are now taking a prescription monoamine oxidase inhibitor (MAOI) (certain drugs for depression, psychiatric, or emotional conditions, or Parkinson's disease), or for 2 weeks after stopping the MAOI drug. If you do not know if your prescription drug contains a MAOI, ask a doctor or pharmacist before taking this product. If product is brown in color or cloudy If its color is pinkish or darker than slightly yellow or if it contains a precipitate. Ask a doctor before use if you have: Ever been hospitalized for asthma Heart disease High blood pressure Diabetes Thyroid disease Seizures Narrow angle glaucoma A psychiatric or emotional condition Trouble urinating due to an enlarged prostate gland Ask a doctor or pharmacist before use if you are: Taking prescription drugs for asthma, obesity, weight control, depression, or psychiatric or emotional conditions. Taking any drug that contains phenylephrine, pseudoephedrine, ephedrine, or caffeine (such as for allergy, cough-cold, or pain).

1. 1Drug Ineffective1844%
2. 2Asthma1537%
3. 3Erythema1537%
4. 4Off Label Use1537%
5. 5Pruritus1537%
6. 6Acquired Factor V Deficiency1434%
7. 7Bronchopulmonary Aspergillosis Allergic1434%
8. 8Chronic Obstructive Pulmonary Disease1434%
9. 9Coagulation Factor Deficiency1434%
10. 10Coagulation Factor V Level Abnormal1434%
11. 11Dry Skin1434%
12. 12Dyspnoea1434%
13. 13Factor V Leiden Mutation1434%
14. 14Hypertension1434%
15. 15Multiple Allergies1434%

Recent PubMed references pinned to Racepinephrine as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Enhanced electrooxidation/electrocoagulation-ultrafiltration membrane process with S(2)O(4)(2-) for saline algae-containing surface water treatment: Purification and membrane performance.
  Environmental pollution (Barking, Essex : 1987) · 2024 · Song W, Li B, Zhuang Z, et al.
  PMID 38307242DOI 10.1016/j.envpol.2024.123423
• Core-shell structured lignin-stabilized silver nanoprisms for colorimetric detection of sulfur ions.
  International journal of biological macromolecules · 2024 · Chen S, Zheng Y, Gong J, et al.
  PMID 38266862DOI 10.1016/j.ijbiomac.2024.129626
• Selenium and nitrogen co-doped carbon dots with highly efficient electrochemiluminescence for ultrasensitive detection of microRNA.
  Biosensors & bioelectronics · 2023 · Liu J, Chen J, Zhang Y, et al.
  PMID 37660459DOI 10.1016/j.bios.2023.115607
• Mineralization of a Fully Halogenated Organic Compound by Persulfate under Conditions Relevant to in Situ Reduction and Oxidation: Reduction of Hexachloroethane by Ethanol Addition Followed by Oxidation.
  Environmental science & technology · 2023 · Kim TK, Sedlak DL
  PMID 37640476DOI 10.1021/acs.est.3c03489
• Variation in Organizational Clinical Practice Guidelines for Croup.
  Hospital pediatrics · 2023 · Bergmann KR, Lefchak B, Nickel A, et al.
  PMID 37545472DOI 10.1542/hpeds.2023-007221
• Impact of Clinical Guidelines on Hospital Utilization in Children With Croup.
  Hospital pediatrics · 2023 · Lefchak B, Nickel A, Lammers S, et al.
  PMID 37545468DOI 10.1542/hpeds.2023-007181
• Performance, comparison and utilization of reduced sulfur (-2) compounds (S(2-), FeS and SCN(-)) in autotrophic denitrification process by thiosulfate-driven autotrophic denitrifier.
  Environmental research · 2023 · Liu L, Xu Y, Pan H, et al.
  PMID 37224950DOI 10.1016/j.envres.2023.116219
• Predictors of Inpatient Racemic Epinephrine Use in Patients Admitted With Croup.
  Hospital pediatrics · 2023 · Hancock WC, Scott M, Winer JC, et al.
  PMID 36751889DOI 10.1542/hpeds.2022-006870

The 10 most recently updated of 3,501 ClinicalTrials.gov registrations naming Racepinephrine as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
  Recruiting · Phase 2 · Interventional · 461 enrolled · National Cancer Institute (NCI)
  NCT04546399updated 2026-06-12
• PENG Block + LIA For Endoprosthesis Surgery
  Recruiting · Interventional · 100 enrolled · ASST Gaetano Pini-CTO
  NCT07239817updated 2026-06-12
• Hématologie Adulte Prevalence of Adrenal Insufficiency Post-chemotherapy Adrenocorticotropia in Adult Hematology
  Withdrawn · Interventional · 0 enrolled · Rennes University Hospital
  NCT03688789updated 2026-06-12
• Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
  Recruiting · Phase 2 · Interventional · 216 enrolled · Samer Gawrieh
  NCT07060638updated 2026-06-12
• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
  Recruiting · Phase 4 · Interventional · 150 enrolled · Aurinia Pharmaceuticals Inc.
  NCT07611214updated 2026-06-12
• Angiotensin 2 for AKI After OLT
  Active not recruiting · Phase 4 · Interventional · 30 enrolled · University of California, Los Angeles
  NCT04592744updated 2026-06-12
• Treating Exacerbations of Asthma With Oral Montelukast in Children
  Completed · Phase 2 · Interventional · 90 enrolled · Vanderbilt University Medical Center
  NCT05819541updated 2026-06-12
• Vasopressin and Epinephrine Versus Epinephrine Alone in Cardiac Arrest
  Completed · Phase 4 · Interventional · 2,416 enrolled · Hospices Civils de Lyon
  NCT00127907updated 2026-06-11
• Pelvic Pain in Women With Endometriosis
  Completed · Observational · 78 enrolled · National Institute of Neurological Disorders and Stroke (NINDS)
  NCT00073801updated 2026-06-11
• Chest Tube-Delivered Bupivacaine to Decrease Postoperative Pain After Cardiac Surgery
  Not yet recruiting · Early phase 1 · Interventional · 60 enrolled · University of Calgary
  NCT07643506updated 2026-06-11

Frequently asked questions

What is Racepinephrine used for?

According to FDA labeling, Racepinephrine carries indications including: Uses For temporary relief of mild symptoms of intermittent asthma: Wheezing Tightness of chest Shortness of breath. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.

What are the brand names for Racepinephrine?

Racepinephrine is marketed under brand names including Asthmanefrin, S-2.